Progyny Secures $14,700,000 Series B Round

  • Feed Type
  • Date
    6/29/2016
  • Company Name
    Progyny
  • Mailing Address
    99 Hudson Street 7th Floor New York, NY 10013 USA
  • Company Description
    Progyny is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions. We are committed to helping ensure that patients control their fertility journey and achieve the best possible outcome.
  • Website
    http://www.progyny.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,700,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The Series B financing will be used to accelerate the growth of its proprietary technology as well as its fertility benefits solution to enterprise customers. The new funds will also be utilized to launch new products and services including Progyny’s new app which is focused on the education and empowerment of those trying to conceive, going through fertility treatment, or interested in preserving their fertility through egg freezing.
  • M&A Terms
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Undisclosed

Trending on Xconomy